SCHEMBL30217795

SCHEMBL30217795

O=C(O)c1ccc(Br)c2nccnc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.46
ALDH1A1 P00352 4/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
KDM4A O75164 2/20 0.43
EGLN1 Q9GZT9 2/20 0.43
KDM4C Q9H3R0 2/20 0.43
KDM6B O15054 1/20 0.43
KDM6A O15550 1/20 0.43
TET3 O43151 1/20 0.43
KDM4B O94953 1/20 0.43
KDM5C P41229 1/20 0.43
KDM4D Q6B0I6 1/20 0.43
TET2 Q6N021 1/20 0.43
ALKBH5 Q6P6C2 1/20 0.43
TET1 Q8NFU7 1/20 0.43
FTO Q9C0B1 1/20 0.43
KDM2A Q9Y2K7 1/20 0.43
KDM3A Q9Y4C1 1/20 0.43
TP53 P04637 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25097311 1.00 KDM4E (0.46) KDM4EALDH1A1L3MBTL1KDM4AEGLN1
SCHEMBL28512682 0.78 KDM4E (0.57) KDM4EALDH1A1L3MBTL1KDM4AEGLN1
SCHEMBL1126280 0.78 KMT2A (0.62) KDM4EALDH1A1L3MBTL1KDM4AEGLN1
SCHEMBL6962756 0.78 KDM4E (0.68) KDM4EALDH1A1L3MBTL1KDM4AEGLN1
SCHEMBL31082793 0.78 KDM4E (0.49) KDM4EALDH1A1KMT2ATDP1MAPT
SCHEMBL1126077 0.78 MAPK1 (0.44) KDM4EALDH1A1L3MBTL1TP53KMT2A
SCHEMBL30439125 0.78 MAPK1 (0.44) KDM4EALDH1A1L3MBTL1TP53KMT2A
SCHEMBL30530504 0.77 KDM4E (0.47) KDM4EALDH1A1L3MBTL1KDM4AEGLN1
SCHEMBL24317845 0.77 KDM4E (0.47) KDM4EALDH1A1L3MBTL1KDM4AEGLN1
SCHEMBL3500515 0.76 KDM4E (0.42) KDM4EALDH1A1L3MBTL1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4395891-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING Remix Therapeutics Inc. (US) 2024-07-10 EP disclosed
WO-2023034811-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING REMIX THERAPEUTICS INC. (US) 2023-03-09 WO disclosed
EP-4110464-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING Remix Therapeutics Inc. (US) 2023-01-04 EP disclosed